In addition, some studies have shown ANGPT2 is prognostic biomarker in cancers (38, 39), and whether ANGPT2 is associated with the outcome or can be used to risk stratification in patients with AAD is also needed to be confirmed. Here, ANGPT2 is linked to cancer.